Bank of Montreal Can Has $312,000 Stake in Addus HomeCare Co. (NASDAQ:ADUS)

featured-image

Bank of Montreal Can raised its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 17.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,493 shares of the company’s stock after purchasing an additional 369 shares during the quarter. Bank of Montreal [...]

Bank of Montreal Can raised its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 17.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

The firm owned 2,493 shares of the company’s stock after purchasing an additional 369 shares during the quarter. Bank of Montreal Can’s holdings in Addus HomeCare were worth $312,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds also recently modified their holdings of the company.



Principal Financial Group Inc. grew its position in Addus HomeCare by 17.5% in the third quarter.

Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after purchasing an additional 75,409 shares in the last quarter. TimesSquare Capital Management LLC grew its stake in shares of Addus HomeCare by 28.

5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after buying an additional 78,835 shares in the last quarter. American Century Companies Inc.

lifted its stake in Addus HomeCare by 695.8% in the fourth quarter. American Century Companies Inc.

now owns 284,346 shares of the company’s stock valued at $35,643,000 after acquiring an additional 248,613 shares during the last quarter. Summit Creek Advisors LLC increased its stake in shares of Addus HomeCare by 0.3% during the 4th quarter.

Summit Creek Advisors LLC now owns 208,562 shares of the company’s stock worth $26,143,000 after purchasing an additional 644 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Addus HomeCare by 10.

2% during the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after purchasing an additional 16,997 shares during the period.

95.35% of the stock is owned by institutional investors and hedge funds. Addus HomeCare Stock PerformanceNASDAQ:ADUS opened at $98.

86 on Thursday. The business’s fifty day moving average is $98.47 and its 200 day moving average is $116.

52. The firm has a market cap of $1.80 billion, a price-to-earnings ratio of 22.

62, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.

72. Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The company reported $1.

26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09).

The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million.

Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%.

Equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analysts Set New Price TargetsSeveral brokerages have recently weighed in on ADUS. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th.

Stephens reissued an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie restated an “outperform” rating and issued a $129.

00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.

00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, JMP Securities reissued a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a report on Tuesday.

One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $139.00.

Read Our Latest Research Report on ADUSAddus HomeCare Company Profile (Free Report)Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.Recommended StoriesFive stocks we like better than Addus HomeCareWhat is a Dividend Harvesting Strategy and How Can Investors Profit from it?Can IBM’s Q1 Earnings Spark a Breakout for the Stock?How to Start Investing in Real EstateS&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?2 Fintech Stocks to Buy Now and 1 to AvoidFundamentally Sound, These 5 Stocks Sold Off AnywayWant to see what other hedge funds are holding ADUS? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report)..